Efficacy and safety evaluation of plasma-derived human coagulation factor Ⅷ in patients with hemophilia A

Objective To evaluate the efficacy and safety of plasma-derived human coagulation factor Ⅷ (FⅧ) in the treatment of patients with hemophilia A. Methods A multi-center and open, SAT(single-arm trials) clinical study was conducted. A total of 54 subjects with hemophilia A were enrolled in 5 research c...

Full description

Bibliographic Details

Published in:	Zhongguo shuxue zazhi
Main Authors:	Shumin LIANG, Wei ZHANG, Guixiang JIANG, Zhongliang SUN, Yan ZHENG, Chen YAN
Format:	Article
Language:	Chinese
Published:	Institute of Blood Transfusion of Chinese Academy of Medical Sciences 2023-09-01
Subjects:	hemophilia a human coagulation factor ⅷ safety efficacy
Online Access:	https://www.cjbt.cn/thesisDetails#10.13303/j.cjbt.issn.1004-549x.2023.09.007&lang=en